4//SEC Filing
MacDonald James J. 4
Accession 0001562180-22-001784
CIK 0001770121other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:01 PM ET
Size
9.2 KB
Accession
0001562180-22-001784
Insider Transaction Report
Form 4
MacDonald James J.
See Remarks
Transactions
- Award
Common Stock
2021-11-15$18.23/sh+1,000$18,233→ 429,750 total - Sale
Common Stock
2022-02-18$6.28/sh−333$2,091→ 429,417 total
Holdings
- 125,000(indirect: By Trust)
Common Stock
- 125,000(indirect: By Trust)
Common Stock
- 7,812(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock of Sana Biotechnology, Inc. (the "Issuer") pursuant to the Sana Biotechnology, Inc. 2021 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 3, 2021 through November 15, 2021. This transaction is exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2021.
- [F3]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001830054
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:01 PM ET
- Size
- 9.2 KB